Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

Kozlitina, Julia, Smagris, Eriks, Stender, Stefan, Nordestgaard, Børge G, Zhou, Heather H, Tybjærg-Hansen, Anne, Vogt, Thomas F, Hobbs, Helen H, Cohen, Jonathan C·2014·Nature Genetics

DOI 10.1038/ng.2901

Cited by (1,000)

Items 901–1,000 of 1,000

Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease
Zobair M. Younossi, J.Michael Estep, Sean C. Felix, Brian P Lam, Zaid Younossi, Andrei Racila, Maria Stepanova · 2024 · Diabetes Research and Clinical Practice
Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC)
Davide Misceo, Gabriele Mocciaro, Simona D’Amore, Michèle Vacca · 2024 · Nutrition & Metabolism
Epidemiology and Risk Factors for Alcoholic Liver Disease
Mariana Lazo, Mack C. Mitchell · 2015 · Springer eBooks
An adult‐based genetic risk score for liver fat associates with liver and plasma lipid traits in children and adolescents
Yun Huang, Sara Elizabeth Stinson, Helene Bæk Juel, Morten Asp Vonsild Lund, Louise Aas Holm, Cilius Esmann Fonvig, Trine Nielsen, Niels Grarup, Oluf Borbye Pedersen, Michael Christiansen et al. · 2023 · Liver International
Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus
Jia Liu, Wenqian Qi, Song Wang, Yonggui Zhang, Xu Wang, Derong Sun, Yanhui Xu, Jingyi Shi, Honglei Duan, Qian Zhang et al. · 2023 · Lipids in Health and Disease
The efficacy of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity
Natalia Zakharova, Chenguang Luo, Raisa A. Aringazina, Vadim O. Samusenkov · 2023 · Lipids in Health and Disease
Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?
Adele Tulone, Grazia Pennisi, Carlo Ciccioli, Giuseppe Infantino, Claudia La Mantia, Roberto Cannella, Francesco Mercurio, Salvatore Petta · 2024 · United European Gastroenterology Journal
Transmembrane 6 superfamily 1 (Tm6sf1) is a novel lysosomal transmembrane protein
Wing Yip Tam, Liwen Jiang, Kin Ming Kwan · 2014 · PROTOPLASMA
Gene-exercise interactions in the development of cardiometabolic diseases
Kumpei Tanisawa, Masashi Tanaka, Mitsuru Higuchi · 2016 · The Journal of Physical Fitness and Sports Medicine
Old-fashioned and newly discovered biomarkers: the future of NAFLD-related HCC screening and monitoring
Roberto Piciotti, Miriam Longo, Adele Agresta, Erika Paolini, Annalisa Cespiati, Marica Meroni, Paola Dongiovanni · 2022 · Hepatoma Research
Genomic approaches to explore susceptibility and pathogenesis of alcohol use disorder and alcohol-associated liver disease
Trina M. Norden‐Krichmar, Daniel Miller Rotroff, Tae-Hwi Linus Schwantes-An, Ramon A. Bataller, David A Goldman, Laura E. Nagy, Suthat Liangpunsakul · 2023 · Hepatology
Clinical workup of fatty liver for the primary care provider
Thomas Jensen, Amanda C. Wieland, Melanie Cree‐Green, Kristen J. Nadeau, Shelby A. Sullivan · 2018 · Postgraduate Medicine
Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease
Marica Meroni, Miriam Longo, Paola Dongiovanni · 2020 · Exploration of Medicine
Insights into blood lipids from rare variant discovery
Ellen M. Schmidt, Cristen J. Willer · 2015 · Current Opinion in Genetics & Development
Clinical Epidemiology of NAFLD
Donghee Kim, Osama Siddique, Brandon J. Perumpail, Aijaz Ahmed · 2018 · Springer eBooks
[Use of Ommaya CSF reservoir for refractory chronic subdural hematoma].
Masaharu Sato, K Iwatsuki, Chihiro Akiyama, Yoshiyuki Masana, Toshiki Yoshimine, T Hayakawa · 1999 · PubMed
Lipoprotein Metabolism and Cholesterol Balance
Mariana Acuña, David E. Cohen · 2020 · Wiley eBooks
Panomics in metabolic dysfunction-associated steatotic liver disease: unravelling the drivers of disease heterogeneity
Carlos Jose Pirola, Silvia Sookoian · 2025 · Clinical and Molecular Hepatology
Genetic polymorphisms associated with metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk susceptibility in the Chinese Han population
Mingjia Dai, Yan Li, Jing Zhang, Yuhua Ruan, Ye Liu, Jungui Hao, Fang Ji, Xuebing Yan · 2025 · Human Genomics
Decoding the heterogeneity of liver-resident macrophages in chronic liver diseases: therapeutic responses to immunomodulatory strategies
Renbin Ouyang, Xiaocheng Li, Jianhua Hao, Jie Lin, Hui Y. Lan, Jing Peng, Xinmin Li, Zhiliang Tian, Yu Sun · 2025 · Frontiers in Pharmacology
Cause-specific mortality in lean individuals with metabolic dysfunction-associated steatotic liver disease
Ziqi Zhang, Jiying Lu, Milian Chen, Liang Dai, Yingying Xiang, Zhidong Liu, Ying Cao, Wei Sheng, Chunlin Li, Deji Song et al. · 2025 · Lipids in Health and Disease
Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options
Ruizhe Ren, Xiao Liang, Xiyang Wei · 2026 · Molecular Biomedicine
Genetics of MASLD: a diabetes perspective
Josh Bilson, Hanieh Yaghootkar · 2026 · Diabetologia
Mitochondrial Dysfunction in Metabolic-Syndrome-Related MASLD/MASH: Metabolic Mechanisms and Therapeutic Perspectives
Jin Jin, C Chia-Kai Yang · 2026 · Metabolites
A data-driven framework reconstructs the molecular continuum of human MASLD progression
Ioannis Kamzolas, Thodoris Koutsandreas, Charlie George Barker, Anna Vathrakokoili Pournara, Harry Weston, Naoto Fujiwara, Yujin Hoshida, Quentin Mark Anstee, Michele Vacca, Irene Papatheodorou et al. · 2026 · Nature Metabolism
MASLD and the cardiovascular-kidney-liver-metabolic syndrome
Angeliki M. Angelidi, Chrysoula Boutari, Michail Kokkorakis, Konstantinos Stefanakis, Dimitri P. Mikhailidis, George Jacob, Christos Socrates Mantzoros · 2026 · Endocrine Reviews
Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
Huixia Liu, Chun Zhang, Jing Xiong · 2022 · Kidney Diseases
Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis
Ruofan Li, Kaiyan Su, Tianzhun Wu, Li Xu, Wenyu Song, Dandan Sun, Tao Zeng, Jinzhang Chen, Haibei Xin, Yuanfeng Li et al. · 2025 · BMC Genomics
The impact of polymorphism in PNPLA3 and TM6SF2 genes on the susceptibility and survival of hepatitis C-related hepatocellular carcinoma
Samar Samir Youssef, Eman Abd El Razek Abbas, Asmaa M. Elfiky, Sameh Mohamed Seif, Mohamed Mahmoud Nabil, Hend Ibrahim Shousha, Ashraf Omar Abdelaziz · 2022 · Egyptian Liver Journal
TM6SF2-rs58542926 Genetic Variant Modifies the Protective Effect of a “Prudent” Dietary Pattern on Serum Triglyceride Levels
Ioanna Panagiota Kalafati, Maria Dimitriou, Konstantinos Revenas, Alexander D. Kokkinos, Panos Deloukas, George V. Dedoussis · 2023 · Nutrients
Genetic variation and elevated liver enzymes during childhood, adolescence and early adulthood
Stefan Stender, George Davey Smith, Tom G. Richardson · 2023 · International Journal of Epidemiology
TM6SF2 reduces lipid accumulation in vascular smooth muscle cells by inhibiting LOX-1 and CD36 expression
Tingting Li, Yuting Cui, Tao‐Hua Li, Qiong Xiang, Yanyu Chen, Xi‐Long Zheng, Juan Peng, Zhi‐Han Tang · 2023 · Experimental Cell Research
Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases
Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, Milena Peruhova, Georgi Vasilev, Georgi Vasilev, Metodija Sekulovski, Snezhina Lazova, Milena Gulinac, L Tomov et al. · 2023 · Gastroenterology Insights
Progress and hotspot of diet or exercise therapy in the treatment of non-alcoholic fatty liver disease
Xinyu Shi, Yalan Xiong, Hualing Song, Fen Rong, Nan Tang, L Zhu, Shenyu Li, Jianying Wang, Lei Zhang, Shengfu You et al. · 2024 · Frontiers in Nutrition
Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy
Shahid Habib · 2024 · World Journal of Gastrointestinal Pathophysiology
Proteome-wide association studies for blood lipids and comparison with transcriptome-wide association studies
Daiwei Zhang, Boran Gao, Qidi Feng, Ani W Manichaikul, Gina Marie Peloso, Russell P. Tracy, Peter Durda, Kent D. Taylor, Yongmei Liu, W. Craig Johnson et al. · 2024 · Human Genetics and Genomics Advances
Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation
Ville Liukkonen, Maria Semenova, Kati Hyvärinen, Jouni Lauronen, Jukka Partanen, Johanna T. Arola, Arno J. Nordin, Martti A. Färkkilä, Fredrik O. Åberg · 2025 · Liver International
Metabolic dysfunction associated steatotic liver disease is associated with an increased risk of multiple respiratory system diseases
Bofu Liu, Jia Yu, Zhihan Gu, Yizhou Li, Yiheng Zhou, Yu Cao · 2025 · Scientific Reports
Advances in identifying risk factors of metabolic dysfunction-associated alcohol-related liver disease
Rui-Qi Ye, Yi‐Fan Chen, Chang Ma, Xi Cheng, Wei Guo, Sha Li · 2025 · Biomedicine & Pharmacotherapy
Intestinal TM6SF2 and the gut-liver axis in MASLD: new insights
Markos Kalligeros, Linda L Henry, Zobair M. Younossi · 2025 · Metabolism and Target Organ Damage
Hepatocyte-specific depletion of ubiquitin regulatory X domain containing protein 8 accelerates fibrosis in a mouse non-alcoholic steatohepatitis model
Norihiro Imai, Michitaka Suzuki, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Kazuhiko Hayashi, Masatoshi Ishigami, Yoshiki Hirooka, Tetsuya Ishikawa, Hidemi Goto et al. · 2017 · Histochemistry and Cell Biology
Managing the Burden of Non-NASH NAFLD
Christopher J. Danford, Jorge E. Sanchez, Kathleen E. Corey · 2017 · Current Hepatology Reports
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon
Fioravante Capone, Antonio De Vincentis, Elisabetta Ferraro, Mariagrazia Rossi, Francesco Motolese, Antonio Picardi, Barbara Giannetti, Giancarlo Di Battista, Umberto Vespasiani Gentilucci, Vincenzo Di Lazzaro · 2020 · Clinical Neurology and Neurosurgery
RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases
Jianli Zhou, Yuzhen Zhao, Shanshan Wang, Mo‐Xian Chen, Shaoming Zhou, Chen Chen · 2021 · Frontiers in Molecular Biosciences
Computational Pipeline for Next-Generation Sequencing (NGS) Studies in Genetics of NASH
Adrián Salatino, Silvia C. Sookoian, Carlos Jose Pirola · 2022 · Methods in molecular biology
Hepatocellular carcinoma on the background of nonalcoholic fatty liver disease: epidemiological update
Elvire Desjonqueres, Elia Gigante · 2022 · Hepatoma Research
The effects of seaweed supplementation consumption for improvement of liver injury in patients with non-alcoholic fatty liver disease: a systematic review
Muhammad Adnan, Miranti Dewi Pramaningtyas · 2022 · Clinical and Experimental Hepatology
Wnt16Promotes Vascular Smooth Muscle Contractile Phenotype and Function via Taz (Wwtr1) Activation in MaleLDLR−/−Mice
Abraham Behrmann, Dalian Zhong, Li Li, Shangkui Xie, Megan Mead, Parastoo Sabaeifard, Mohammad Goodarzi, Andrew S. Lemoff, Julia Kozlitina, Dwight A. Towler · 2023 · Endocrinology
Combination of risk alleles of PNPLA3, TM6SF2, and HSD17B13 of donors can predict recurrence of steatotic liver disease after liver transplantation
Kenta Makino, Takamichi Ishii, Satoshi Ogiso, Akiyoshi Nakakura, Takahiro Nishio, Ken Fukumitsu, Elena Yukie Uebayashi, Fumiaki Munekage, Hiroshi Horie, Kentaro Iwaki et al. · 2024 · Hepatology Research
Genetic and Hormonal Control of Hepatic Steatosis in Female and Male Mice
Frode Norheim, S. Hui, Jake Lusis · 2016 · Journal of Hepatology
Hereditary Persistence of Alpha-Fetoprotein Is Associated with the —119G>A Polymorphism in AFP Gene
Neha R. Deshpande, Radhika Chavan, Govardhan Bale, Urmila Steffie Avanthi, Mohsin Aslam, Mohan J. Ramchandani, D. Nageshwar Reddy, Vishnubhotla Venkata Ravikanth · 2017 · ACG Case Reports Journal
Functional Foods for the Management of Non-Alcoholic Fatty Liver Disease
Venkateish V. Palanisamy, Nivya Vijayan, Vani Vijay, Baskaran Vallikannan, Madan Kumar Perumal · 2021 · IntechOpen eBooks
Non-alcoholic Fatty Liver Disease
Sangwon F. Kim, Jang Hyun Choi · 2023 · Springer eBooks
Mendelian Randomization Analysis Dissects the Relationship between NAFLD, T2D, and Obesity and Provides Implications to Precision Medicine
Liu, Zhipeng, Zhang, Yang, Graham, Sarah, Pique-Regi, Roger, Dong, Xiaocheng Charlie, Chen, Y. Eugene, Willer, Cristen, Liu, Wanqing · 2019
PNPLA3-Ile148Met and TM6SF2-Glu167Lys increase susceptibility to metabolic dysfunction-associated steatotic liver disease in children
Hengpan Yao, Zhiyi Xia, Ying Liu, MengJun Dong, Kairui Yang, Fang Zhou · 2025 · Frontiers in Endocrinology
Synergistic therapeutic strategies for metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus: molecular insights and clinical advances
Bo Jie Zhu · 2026 · Frontiers in Endocrinology
TM6SF2 in Hepatic Lipid Metabolism and Chronic Liver Disease
Mustafa Al-Nakeb, Nils Haep · 2026 · Livers
Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity
Joseph L. Herman, Peter Dornbos, Karl Landheer, Benjamin J. Geraghty, Marc A. Egerman, Duc Phan, Mary Germino, Jason W. Mastaitis, Johnathon R. Walls, Luca Andrea Lotta et al. · 2026 · Nature Communications
Monogenic and Polygenic Risk in Common Liver Diseases: Implications for Clinical Care
Veeral H. Ajmera, Daniel Q. Huang, Vincent Lingzhi Chen, K. Rajender Reddy · 2026 · Gastroenterology
Genetic variations associated with spleen-yang deficiency pattern of non-alcoholic fatty liver disease: A candidate gene study
Zhan Gu, Qiao Wang, Huayu He, Dong Li, Ruirui Wang, Lei Zhang, Guang Ji, Baocheng Liu · 2019 · European Journal of Integrative Medicine
Impact of fibrosis on liver‐related event incidence in nonalcoholic fatty liver disease: A multicenter observational study
Kazuaki Chayama, Akira Hiramatsu, Toshihide Shima, Yoshito Itoh, Kanji Yamaguchi, Tomoaki Nakajima, Kyoko Tomita Hoshikawa, Yusuke Kawamura, Norio Akuta, Kiyoaki Ito et al. · 2023 · Hepatology Research
Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort study
Julia Kozlitina, Naomi M Cohen, Drew Sturtevant, Jonathan C. Cohen, Cathi Murphey-Half, Jerome G. Saltarrelli, Peter Jindra, Medhat Z. Askar, Christine S. Hwang, Parsia A. Vagefi et al. · 2023 · EClinicalMedicine
Genetic Risk Phenotypes for Type 2 Diabetes Differ with Ancestry in US Adults with Diabetes and Overweight/Obesity
Lauren Adele Fowler, José R. Fernández, Patrick Mahlen O'Neil, Vibhu Parcha, Pankaj Kumar Arora, Naman S. Shetty, Michelle I. Cardel, Gary D. Foster, Barbara Ann Gower · 2024 · Archives of Medical Research
Association between single nucleotide polymorphisms in PNPLA3, TM6SF2 and MBOAT7 genes and markers of cancer aggressiveness in a Sri Lankan NASH-related HCC cohort
Saumya Madushani Samarasinghe, Asanka Sudeshini Hewage, Rohan Chaminda Siriwardana, Kamani Hemamala Tennekoon, Madunil Anuk Niriella, Sumadee De Silva, Visula Abeysuriya · 2025 · BMC Gastroenterology
Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non‐alcoholic fatty liver disease
Jane I. Grove, Prarthana Thiagarajan, Stuart Astbury, Rebecca Harris, Toby Delahooke, Indra Neil Guha, Guruprasad Padur Aithal · 2018 · Liver International
POLYMORPHISM RS58542926 OF THE TM6SF2 GENE IN CHRONIC NON-INFECTIOUS LIVER DISEASES IN THE YAKUT POPULATION
A.T. Dyakonova, Х.А. Куртанов, Nadezhda Ivanovna Pavlova, Н. А. Соловьева, Y.A. Soloveva, Н.П. Филиппова, Т.Н. Александрова · 2019 · Современные проблемы науки и образования
Perturbation of Wnt/β‐catenin signaling and sexual dimorphism in non‐alcoholic fatty liver disease
Matthew M. Yeh, Xiuhui Shi, Jingxuan Yang, Min Li, Kar-Ming A. Fung, Sayed S. Daoud · 2022 · Hepatology Research
The role of polymorphisms of PNPLA3, MBOAT7, and TM6SF2 in the development of non-alcoholic fatty liver disease in metabolic syndrome
Olga Valentinovna Smirnova, Лагутинская Дарья Владимировна · 2022 · Obesity and metabolism
Non-alcoholic fatty liver disease establishment and progression: genetics and epigenetics as relevant modulators of the pathology
Camila Cristiane Pansa, Letícia Ramos Molica, Karen C. M. Moraes · 2022 · Scandinavian Journal of Gastroenterology
Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus
Kanuengnit Choochuay, Punna Kunhapan, Apichaya Puangpetch, Sissades Tongsima, Pornpen Srisawasdi, Abhasnee Sobhonslidsuk, Somnuek Sungkanuparph M. D, Mohitosh Biswas, Chonlaphat Sukasem · 2024 · World Journal of Hepatology
From “two hit theory” to “multiple hit theory”: Implications of evolution of pathogenesis concepts for treatment of non-alcoholic fatty liver disease
Qin Liu, Chun-Yan Niu · 2019 · World Chinese Journal of Digestology
PNPLA3 L148M (rs738409) polymorphism as a risk for new onset diabetes mellitus and obesity in non-NASH/cryptogenic living related donor liver transplant recipients
Osama Desouky Elbahr, Amany A. Saleh, Lamiaa H. Bakery · 2020 · Gene Reports
The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study
Goh Eun Chung, Eun‐Soon Shin, Min‐Sun Kwak, Jong In Yang, Jong-Eun Lee, Eun Kyung Choe, Jeong Yoon Yim · 2020 · BMC Gastroenterology
Alcohol or Not: A Review Comparing Initial Mechanisms, Contributing Factors, and Liver Transplantation Outcomes Between Alcoholic and Nonalcoholic Steatohepatitis
Chung-Shiung Wen, Cheng‐Maw Ho · 2018 · European Medical Journal
Cardiovascular risk in pediatric nonalcoholic fatty liver disease: recent advances
Shankar Baskar, Simone Jhaveri, Naim Alkhouri · 2015 · Clinical Lipidology
Identification of eQTLs for Hepatic Xbp1s and Socs3 Gene Expression in Mice Fed a High-Fat, High-Caloric Diet
Sarina Pasricha, Jane P. Kenney‐Hunt, Kristy Anderson, Nadereh Jafari, Rabea A. Hall, Frank Lammert, James M. Cheverud, Richard M. Green · 2015 · G3 Genes Genomes Genetics
Genetic Variations Linked to Hepatocellular Carcinoma: Personalized Medicine Takes a Step Forward
Parul Dureja Agarwal, Michael Ronan Lucey · 2018 · The American Journal of Gastroenterology
MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease
Stefano Romeo · 2020 · Gastroenterology
Electronic Health Record-Based Genome-Wide Meta-Analysis Provides New Insights on the Genetic Architecture of Non-Alcoholic Fatty Liver Disease
Nooshin Ghodsian, Erik Abner, Connor A. Emdin, Émilie Gobeil, Nele Taba, Mary E. Haas, Nicolas Perrot, Hasanga D. Manikpurage, Éloi Gagnon, Jérôme Bourgault et al. · 2021 · SSRN Electronic Journal
TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
Andrea Marco Caddeo, Rosellina Margherita Mancina · 2024 · Clinical and Molecular Hepatology
Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy?
Tomotaka Mori, Eisuke Ozawa, Ryu Sasaki, Akane Shimakura, Kosuke Takahashi, Yoko Kido, Yasuko Kanda, Satoshi Matsuo, Kazuaki Tajima, Asami Beppu et al. · 2024 · JGH Open
A novel human hepatocyte cell line to study PNPLA3-associated steatotic liver disease
Gary Huang, Daniel F. Wallace, V. Nathan Subramaniam · 2025 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Genetic risk score correlates with immune profile and risk of HCC and cirrhosis development in Hispanics with MASLD
Siyu Fu, Zwier M. A. Groothuismink, Domingo Balderramo, Ângelo Zambam de Mattos, Lísia Hoppe, Enrique Carrera, Javier Díaz Ferrer, Jhon Edison Prieto Ortíz, Jesús M. Bañales, Marco A. Arrese et al. · 2025 · JHEP Reports
Genetic predeterminants and recent advancements in steatotic liver disease: A roadmap toward precision hepatology
Ganesh Kumar, Yash R. Shah, Abeer Shahzad, Khadija Jameel, David Guevara-Lazo, Najia Ali Khan, Dushyant Singh Dahiya, Manesh Kumar Gangwani, Rakshana Ravichandran, Ravi J. Patel et al. · 2025 · World Journal of Hepatology
Évolution de la nomenclature des maladies hépatiques stéatosiques : vers un changement de paradigme
Philippe Halfon · 2025 · La Revue de Médecine Interne
CILP2: From ECM Component to a Pleiotropic Modulator in Metabolic Dysfunction, Cancer, and Beyond
Zheqiong Tan, Suotian Liu, LU Zhong-xin · 2026 · Biomolecules
Genetic Susceptibility Versus Fibrosis Progression in North Indian Metabolic Dysfunction–Associated Steatotic Liver Disease: Distinct Roles of APOC3 and PNPLA3 in a Candidate Gene Study
Nandini Tomar, Sangeeta Choudhury, Anil Arora, Praveen Sharma, Rishikant Vaibhav, Rizwana Hasan, Shayesta Jan, Rajwinder Kaur, Tarun Rajput, Medha Sravanthi Lomada et al. · 2026 · Journal of Clinical and Experimental Hepatology
Metabolic-associated steatotic liver disease in children and adolescents: a scoping review and narrative synthesis of epidemiology, risk factors, and screening approaches with emerging implications for sub-Saharan Africa
Bruno Basil, Peace Ngozi Okoro · 2026 · Frontiers in Endocrinology
FGF1 orchestrates circadian hepatic triglyceride secretion
Benan Pelin Sermikli, Sihao Liu, Kyeongkyu Kim, Linnea Hases, Tim van Zutphen, Ashley Anne Untereiner, Jocelyn Torres, Mingxiao He, Lillian Crossley, Yang David Dai et al. · 2026 · Nature Communications
Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management
Takashi Kobayashi, Masato Yoneda, Ajay Duseja, Jian-Gao Fan, Alexander Nersesov, Atsushi Nakajima · 2026 · Clinics in Liver Disease
Genetic risk of steatotic liver disease: Pathogenesis, prognosis, and implications for treatment
Julia Kozlitina, Stefano Romeo, Helen H. Hobbs · 2026 · Hepatology
Lean Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): Pathophysiology, Diagnostic Challenges, Clinical Outcomes, and Management
Noor Albusta, Sara Isa, Hussain Nasser Saleh Alrahma · 2026 · Diseases
The NLRP3 inflammasome in metabolic dysfunction-associated steatotic liver disease: role and advances in therapeutic targeting
Sheng Wei, Yanlang He, Chen Luo, Xiaofeng He · 2026 · Frontiers in Immunology
FNIP1 variants are associated with favourable metabolism in 1 million humans
George Hindy, Rene C. Adam, Olukayode Ayodeji Sosina, Dwaine S. Pryce, David Blair, Joseph Herman, Joseph Lee, Peter Dornbos, Ernst Mayerhofer, Arthur Gilly et al. · 2026 · Nature
Molecular mechanisms and pathogenesis of MASH
Suchira Gallage, Olivier Govaere, Quentin Mark Anstee, Gerald I. Shulman, Frank Tacke, Mathias F Heikenwälder · 2026 · Nature
Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making
Mayada Metwally, Mohammed Eslam, Jacob George · 2017 · Current Hepatology Reports
Referral Patterns for Patients with Nonalcoholic Fatty Liver Disease
Elias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, Anders Ellekaer Junker, Majken K. Jensen, Lise Lotte Gluud · 2021 · Journal of Clinical Medicine
Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contexts
Naoto Kubota, Naoto Fujiwara, Yujin Hoshida · 2022 · Advances in cancer research
Polymorphisms of HSD17B13, GCKR, HFE, and CP as factors of the development of non-alcoholic fatty liver disease and comorbid diseases
Olga Valentinovna Smirnova, Лагутинская Дарья Владимировна · 2023 · Meditsinskiy sovet = Medical Council
Loss of the E3 ubiquitin ligase MARCHF6 alters hepatic lipid metabolism and drives spontaneous hepatosteatosis
Sachdev, Vinay, van Loon, Nienke M., Kingma, Jenina, Ottenhoff, Roelof, Tan, Josephine M.E., van den Berg, Marlene, Duijst, Suzanne, Jongejan, Aldo, Levels, Johannes H.M., Rensen, Patrick C.N. et al. · 2026 · Molecular Metabolism